Last week Bollywood star Aamir Khan criticized doctors for prescribing costly branded medicines and argued that generics are just as good. And now it seems India is considering offering generic drugs for free to patients at government-run clinics.
After Prime Minister Manmohan Singh backed the scheme, the Planning Commission has reportedly allocated $18 million to start the ball rolling. The only glitch: the whole whack will cost more like $5 billion over the next five year plan.
Why no love for Big Pharma?
Currently 78 percent of health expenditure in India is borne by patients – and 72% of this is spent on drugs.
India has long led the battle against high-cost medicines, and only recently adopted the tough patent laws used in the US and Europe. For decades, India only honored patents on the process through which a medical formulation was made, rather than the drugs themselves, so companies like Dr. Reddy's and Ranbaxy were legally allowed to reverse engineer patented medicines and sell them under their own labels.
Those days are over now, more or less. But Indians, Africans and even a whole lot of Americans are still poor. So it makes some sense to try to make medicine cheaper.
Currently only 22 percent of Indians have access to public healthcare, reports health.india.com. The government estimates this number will reach 52% by 2017. Then government aims to provide generic medicines at 160,000 sub-centres, 23,000 primary health centres, 5,000 community health centres and 640 district hospitals. Some 348 essential medicines will be covered, which include anti-AIDS, analgesics, anti-ulcer, anti-psychotic, sedatives, anaesthetic agents, lipid lowering agents, steroids and anti-platelet drugs, the website said.
But would government procurement of generic medicines for dispensing at clinics solve the problem? Or would it just prove a massive sinkhole for public funds, making a bunch of corrupt bureaucrats rich?
Ikea, the Swedish furniture retailer, plans to invest $1.9 billion in India and open 25 stores across the country.
Fitch also warned the rating of Asia's third-largest economy was at risk of being downgraded to junk status.